| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
§||
From the Blood and Cancer Research Program,*
Hospital
for Sick Children and the Departments of
Immunology,
Pathology,||
and
Pediatrics,
University of
Toronto, Toronto, Ontario, Canada; the Department of
Genetics,§
North York General Hospital,
Toronto, Ontario, Canada; and the Department of
Pediatrics,¶
University of Vermont College of
Medicine, Burlington, Vermont
Endoglin is predominantly expressed on endothelium and is mutated in hereditary hemorrhagic telangiectasia (HHT) type 1 (HHT1). We report the analysis of endoglin in tissues of a newborn (family 2), who died of a cerebral arteriovenous malformation (CAVM), and in a lung specimen surgically resected from a 78-year-old patient (family 5), with a pulmonary AVM (PAVM). The clinically affected father of the newborn revealed a novel mutation that was absent in his parents and was identified as a duplication of exons 3 to 8, by quantitative multiplex polymerase chain reaction. The corresponding mutant protein (116-kd monomer) and the missense mutant protein (80-kd monomer) present in family 5 were detected only as transient intracellular species and were unreactive by Western blot analysis and immunostaining. Normal endoglin (90-kd monomer) was reduced by 50% on peripheral blood-activated monocytes of the HHT1 patients. When analyzed by immunostaining and densitometry, presumed normal blood vessels of the newborn lung and brain and vessels adjacent to the adult PAVM showed a 50% reduction in the endoglin/PECAM-1 ratio. A similar ratio was observed in the CAVM and PAVM, suggesting that all blood vessels of HHT1 patients express reduced endoglin in situ and that AVMs are not attributed to a focal loss of endoglin.
This article has been cited by other articles:
 |
|
 |
|
  S. O. Park, Y. J. Lee, T. Seki, K.-H. Hong, N. Fliess, Z. Jiang, A. Park, X. Wu, V. Kaartinen, B. L. Roman, et al. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2 Blood, January 15, 2008; 111(2): 633 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mei-Zahav, M. Letarte, M. E. Faughnan, S. A. Abdalla, U. Cymerman, and I. B. MacLusky Symptomatic Children With Hereditary Hemorrhagic Telangiectasia: A Pediatric Center Experience Arch Pediatr Adolesc Med, June 1, 2006; 160(6): 596 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sabba, G. Pasculli, P. Suppressa, F. D'Ovidio, G. M. Lenato, F. Resta, G. Assennato, and G. Guanti Life expectancy in patients with hereditary haemorrhagic telangiectasia QJM, May 1, 2006; 99(5): 327 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T G W Letteboer, J J Mager, R J Snijder, B P C Koeleman, D Lindhout, J K Ploos van Amstel, and C J J Westermann Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia J. Med. Genet., April 1, 2006; 43(4): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S A Abdalla and M Letarte Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease J. Med. Genet., February 1, 2006; 43(2): 97 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Letarte, M.-L. McDonald, C. Li, K. Kathirkamathamby, S. Vera, N. Pece-Barbara, and S. Kumar Reduced endothelial secretion and plasma levels of transforming growth factor-{beta}1 in patients with hereditary hemorrhagic telangiectasia type 1 Cardiovasc Res, October 1, 2005; 68(1): 155 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Tille and M.S. Pepper Hereditary Vascular Anomalies: New Insights Into Their Pathogenesis Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1578 - 1590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. van den Driesche, C. L. Mummery, and C. J.J. Westermann Hereditary hemorrhagic telangiectasia: an update on transforming growth factor {beta} signaling in vasculogenesis and angiogenesis Cardiovasc Res, April 1, 2003; 58(1): 20 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Torsney, R. Charlton, A. G. Diamond, J. Burn, J. V. Soames, and H. M. Arthur Mouse Model for Hereditary Hemorrhagic Telangiectasia Has a Generalized Vascular Abnormality Circulation, April 1, 2003; 107(12): 1653 - 1657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Roman, V. N. Pham, N. D. Lawson, M. Kulik, S. Childs, A. C. Lekven, D. M. Garrity, R. T. Moon, M. C. Fishman, R. J. Lechleider, et al. Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels Development, March 8, 2003; 129(12): 3009 - 3019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Satomi, R. J. Mount;, M. Toporsian, A. D. Paterson, M. C. Wallace, R. V. Harrison, and M. Letarte Cerebral Vascular Abnormalities in a Murine Model of Hereditary Hemorrhagic Telangiectasia Stroke, March 1, 2003; 34(3): 783 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M E Begbie, G M F Wallace, and C L Shovlin Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century Postgrad. Med. J., January 1, 2003; 79(927): 18 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-E. Paquet, N. Pece-Barbara, S. Vera, U. Cymerman, A. Karabegovic, C. Shovlin, and M. Letarte Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function Hum. Mol. Genet., June 1, 2001; 10(13): 1347 - 1357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bourdeau, M. E. Faughnan, M.-L. McDonald, A. D. Paterson, I. R. Wanless, and M. Letarte Potential Role of Modifier Genes Influencing Transforming Growth Factor-{beta}1 Levels in the Development of Vascular Defects in Endoglin Heterozygous Mice with Hereditary Hemorrhagic Telangiectasia Am. J. Pathol., June 1, 2001; 158(6): 2011 - 2020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsubara, A. Bourdeau, K. G. terBrugge, C. Wallace, and M. Letarte Analysis of Endoglin Expression in Normal Brain Tissue and in Cerebral Arteriovenous Malformations Stroke, November 1, 2000; 31(11): 2653 - 2660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Jacobson Hereditary Hemorrhagic Telangiectasia : A Model for Blood Vessel Growth and Enlargement Am. J. Pathol., March 1, 2000; 156(3): 737 - 742. [Full Text] [PDF]
|
|
|
|
|
|
C. Atkinson, S. Stewart, P. D. Upton, R. Machado, J. R. Thomson, R. C. Trembath, and N. W. Morrell Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor Circulation, April 9, 2002; 105(14): 1672 - 1678. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
